FDA recalls Verapamil Hydrochloride injectable due to cross contamination
FDA is recalling 8,020 vials of Verapamil Hydrochloride Injection (Lot L300269) distributed nationwide due to potential cross contamination with other products.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recalls are typically assigned severity 1-2 per the rubric. No illnesses or injuries are reported in the source. The cross-contamination hazard is theoretical without evidence of patient impact, warranting Moderate classification.
Plain-English summary
Zydus Pharmaceuticals (USA) Inc. is recalling Verapamil Hydrochloride Injection, USP 10 mg/4 mL. The recall affects 8,020 vials of Lot L300269 (expiration date 07/31/2025) distributed nationwide in the United States. The recall was initiated due to potential cross contamination with other products.
Affected vials can be identified by NDC 70710-1644-1 (vial) and NDC 70710-1644-5 (carton). Healthcare providers should verify whether they have received product from this lot.
The recalled product
- Product
- VERAPAMIL HYDROCHLORIDE (VERAPAMIL HYDROCHLORIDE)
- Brand
- VERAPAMIL HYDROCHLORIDE
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Category
- Drug — Intravenous Medication
- Hazard
- Affected units
- 8,020
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot L300269
- Exp Date 07/31/2025
UPCs (2)
- 0370710164379
- 0370710164355
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Zydus Pharmaceuticals (USA) Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · VERAPAMIL HYDROCHLORIDE
- ModerateInjectable Verapamil Hydrochloride Recalled Due to Cross Contamination Risk
FDA (Drugs) · 2024-07-17
- ModerateCardinal Health Recalls Verapamil Hydrochloride Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
Same manufacturer · Zydus Pharmaceuticals (USA) Inc
See all →- SevereZydus Recalls Hydrocortisone Sodium Succinate Injection for Impurity Failures
FDA (Drugs) · 2026-10-21
- SevereFDA Recalls Mirabegron Tablets Over Nitrosamine Impurity
FDA (Drugs) · 2026-08-12
- SevereErythromycin 500 mg Tablets Recalled for Impurity Above Limits
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- HighIcosapent ethyl capsules recalled after active ingredient oxidized inside capsule
FDA (Drugs) · 2026-03-18
Same hazard · cross contamination
See all →- HighFDA Recalls Performance Pro Nitrile Gloves Due to Defects
FDA (Devices) · 2026-10-07
- HighFDA Recalls Opportunity Pro Nitrile Gloves Due to Manufacturing Defects
FDA (Devices) · 2026-10-07
- HighFDA Recalls Defective Blue Nitrile Patient Examination Gloves
FDA (Devices) · 2026-10-07
- ModerateSage Products Recalls Chlorhexidine Gluconate Cloth Due to Cross Contamination
FDA (Drugs) · 2026-09-09
- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
Similar recalls
- ModerateZydus Recalls Pramipexole Dihydrochloride Tablets Due to Cross Contamination
FDA (Drugs) · 2019-06-26
- ModerateMicafungin injection vials recalled for cross-contamination
FDA (Drugs) · 2024-07-17
- SevereZydus Recalls Pramipexole Dihydrochloride Tablets Due to Cross-Contamination Risk
FDA (Drugs) · 2019-06-26
- ModerateZydus Recalls Methylprednisolone Tablets Due to Cross-Contamination
FDA (Drugs) · 2019-06-26
- ModerateZydus Recalls Pramipexole Dihydrochloride Tablets Due to Cross-Contamination
FDA (Drugs) · 2019-06-26
- ModerateMicafungin for Injection Recalled for Cross Contamination Risk
FDA (Drugs) · 2024-07-17